T-cell-mimicking nanoparticles can neutralize HIV infectivity

Summary

This antiviral study creates nanoscale decoys that imitate the host cells HIV normally attacks. Plasma membrane from CD4 T cells was wrapped around polymeric nanoparticle cores, transferring CD4 together with the CCR5 or CXCR4 coreceptors needed for viral entry. The resulting particles present authentic host binding sites but cannot support infection, so they divert virions away from susceptible cells. They bound the HIV envelope protein gp120 and prevented gp120-mediated killing of bystander CD4 cells. When mixed with intact virus, the decoys also inhibited infection of peripheral-blood mononuclear cells and human-monocyte-derived macrophages in a dose-dependent manner. The principal finding is that a coordinated host-receptor surface can broadly neutralize HIV through competitive binding rather than interference with viral replication machinery. Because the strategy targets the virus's requirement for host entry factors, it may be less vulnerable to viral sequence diversity and may exert less evolutionary pressure than a virus-specific inhibitor. Its significance is a biologically faithful neutralization platform for prevention or therapy. The abstract does not demonstrate in vivo protection, breadth across clinical strains, pharmacokinetics, immune safety, effects on normal receptor signaling, or durability.